News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point
      Drugs & Diseases > Infectious Diseases

      Escherichia coli (E coli) Infections

      Updated: May 11, 2023
      • Author: Ryan P Collier, MD, FACP; Chief Editor: Michael Stuart Bronze, MD  more...
      • Print
      Overview

      Background

      Escherichia coli (E coli) are facultative anaerobic gram-negative bacteria that are part of the normal gastrointestinal system. These organisms mainly are found within the large intestine and frequently are implicated as causes of bacterial infections. These infections can stem from disruption of the gut mucosal membrane leading to local tissue invasion and potential distant tissue seeding through bacteremia. Urinary tract infections are thought to occur via bacterial migration proximally up the ureter, causing colonization and potential infection of the bladder and more proximal structures. Common infections with E coli as a pathogen include cholecystitis, bacteremia, cholangitis, urinary tract infection (UTI), traveler's diarrhea, pneumonia, and neonatal meningitis.

      The genus Escherichia is named after Theodor Escherich, the individual who isolated the type species of the genus. These organisms are gram-negative facultatively anaerobic bacilli, may exist singly or in pairs, utilize both fermentative and respiratory metabolism for energy, and either are nonmotile or motile by peritrichous flagella.E coli has a rapid reproduction time as low as 20 minutes in laboratory conditions and virulence depends on what types of capsular antigens, flagellar antigens, and somatic polysaccharides each strain possesses. [1]

      Next:

      Pathophysiology

      Acute bacterial meningitis

      Most cases of neonatal meningitis cases are caused by group B streptococcal infections and E coli (50% and 20% respectively). Pregnant individuals are at a higher risk for colonization with the K1 capsular antigen strain of E coli. Approximately 80% of the E coli strains that cause neonatal meningitis feature the K1 capsular antigen. This K1 capsular antigen is similar to the group B Neisseria meningitidis capsule, which provides protection from phagocytosis. [2] This strain commonly is observed in neonatal sepsis, which carries a mortality rate of up to 50% if untreated and up to 10% if treated. Some 25-50% of survivors have subsequent neurologic deficits and up to 20% demonstrated developmental abnormalities at 5 years post infection. Low birth weight and a positive cerebrospinal fluid (CSF) culture result portend a poor outcome. [3] In adults, E colimeningitis is rare but occasionally can be seen in those with neurosurgical trauma or complications of neurosurgical procedures with prosthetic device infections. E coli meningitis in an individual with no significant medical comorbidities or those receiving immunosuppression, particularly steroids, should raise suspicion of Strongyloides stercoralis hyperinfection involving the central nervous system. E coli and other enteric bacteria enter the bloodstream attached to the parasite as it migrates through the gut wall toward the lungs as part of its reproductive cycle. While this can occur occasionally, steroids cause alteration in immune regulation and upregulate the generation of filariform larva, which is the stage of the parasite that undergoes this migration. [4]

      Pneumonia

      Pulmonary (Lung) Infections

      E coli respiratory tract infections are extremely uncommon due to this bacteria’s normal habitat of the large intestine being located remotely from the lungs. Pneumonia is thought to be secondary from aspiration or microaspiration. Aspiration is more common in individuals with altered mental status or inability to protect their airway from gastric secretions. This can be due to alcohol use disorder, strokes, electrolyte disturbances (hyper/hyponatremia), and glycemic disorders (hypoglycemia, diabetic ketoacidosis, hyperosmolar hyperglycemic syndrome [HHS]). These disorders put individuals at risk for community acquired pneumonia. Microaspiration can be seen in those with neurological disorders that affect the swallowing mechanism and protection of the airway in both the inpatient and outpatient setting. Severely ill patients and patients who are intubated and sedated are at risk for nosocomial pneumonia due to the inability to consciously protect their airways. Due to the structure of the lungs, predominant lung fields affected are the lower lobes with right greater than left affected. If an individual aspirates while supine, the right upper field may develop pneumonia due to the change in dependent area of the airways.

      Recognize that not all cases of aspiration will lead to pneumonia. Many cases of acute aspiration lead to aspiration pneumonitis, an inflammatory reaction within the lungs, that may present with many of the similar symptoms of pneumonia but not require antimicrobial therapy.

      A parapneumonic effusion and empyema may be secondary to an untreated E coli pneumonia. Lung abscesses from septic emboli may develop from an E coli bacteremia. This mechanism is different from a pneumonia, as the primary route of infection is seeding the lungs through the blood stream and not an infection through the alveoli as seen in pneumonia. The primary etiology of the bacteremia generally is pyelonephritis or intraabdominal infection.

      Unless from a sputum culture isolated during pneumonia, blood culture during bacteremia, or wound culture aspirated from a lung abscess that identifies E coli, it is impossible to distinguish lung pathology caused by this organism from other enteric gram-negative organisms.

      Intra-abdominal infections

      E coli intra-abdominal infections often result from damage to the gut mucosal barrier. This leads to localized infections (eg, diverticulitis, appendicitis) or geographically distant infections (transient splanchnic vein bacteremia leading to pyogenic liver abscesses) (see image below). Complete disruption of the gastrointestinal tract can be spontaneous, traumatic, or anastomotic (prior surgical reconnection site of bowel with failure to heal) in origin with subsequent spillage of gastrointestinal contents, subsequent peritonitis, and complicated by abscess formation. Intra-abdominal abscesses often are polymicrobial as they derive mainly from the gastrointestinal tract that harbors millions of different gram-positive, gram-negative, and anaerobic species. Therefore, E coli plays a component role in these infections but is not the sole cause unless isolated via culture from a sterile space.

      Obstruction of flow of different parts of the gastrointestinal system can lead to subsequent bacterial superinfection (eg, cholecystitis, ascending cholangitis) leading to severe illness and sepsis.

      Escherichia coli liver abscess. Escherichia coli liver abscess.
      View Media Gallery

      Enteric infections

      E coli enteric infections are molecularly and clinically identified through their pathogenicity mechanisms. These strains generally only can be differentiated through molecular mechanisms or presumed through the patient’s clinical syndrome. In total, there are 6 different distinct mechanisms for which E coli can be differentiated – enterotoxigenic E coli (ETEC), enterohemorrhagic E coli (EHEC), enteropathogenic E coli (EPEC), enteroinvasive E coli (EIEC), enteroaggregative E coli (EaggEC), and enteroadherent E Coli (EAEC).

      Despite naming conventions, there are no differences in antimicrobial susceptibilities of these different E coli bacteria. Thus, antibiotics that target E coli would treat all these organisms if they were identified in the same patient. Care must be given in identifying hematochezia or gross blood in the stool, as this may be secondary to dysentery caused by ETEC or EHEC, with lysis of these bacteria though antibiotic treatment potentially leading to release of their toxins and clinical deterioration of the patient.

      As a cause of enteric infections, 6 different mechanisms of action of 6 different varieties of E coli have been reported. Enterotoxigenic E coli (ETEC) is a cause of traveler's diarrhea; enteropathogenic E coli (EPEC) is a cause of childhood diarrhea; enteroinvasive E coli (EIEC) causes a Shigella -like dysentery; enterohemorrhagic E coli (EHEC) causes hemorrhagic colitis that can lead to a diffuse systemic illness of hemolytic-uremic syndrome (HUS); enteroaggregative E coli (EAggEC) primarily is associated with persistent diarrhea in children in developing countries, and enteroadherent E coli (EAEC) is a cause of childhood diarrhea and traveler's diarrhea in Mexico and North Africa. ETEC, EPEC, EAggEC, and EAEC colonize the small bowel, and EIEC and EHEC preferentially colonize the large bowel prior to causing diarrhea.

      Shiga toxin–producing E coli (STEC) is among the most common causes of foodborne diseases. This organism is responsible for several GI illnesses, including nonbloody and bloody diarrhea. Patients with these diseases, especially children, may be affected by neurologic and renal complications, including HUS. Strains of STEC serotype O157-H7 have caused numerous outbreaks and sporadic cases of bloody diarrhea and HUS.

      Kappeli et al looked at 97 non-O157 STECstrains in patients with diarrhea and found that HUS developed in 40% of patients; serotype O26:H11/H most often was associated with this syndrome. [1] Although strains associated with HUS were more likely to harbor STX 2 and EAE compared with those associated with bloody diarrhea, only 5 of the 8 patients with HUS had the STX2 gene; among the 3 patients with EAE -negative, STX2 -negative strains, only STX1 or STX1 and EHXA caused the HUS.

      Urinary tract infections

      The urinary tract is the most common site of E coli infection, and more than 90% of all uncomplicated UTIs are caused by E coli infection. The recurrence rate after a first E coli infection is 44% over 12 months. E coli UTIs are caused by uropathogenic strains of E coli. E coli causes a wide range of UTIs, including uncomplicated urethritis cystitis, symptomatic cystitis, pyelonephritis, acute prostatitis, prostatic abscess, and sepsis from an ascending urinary tract infection. Uncomplicated cystitis occurs primarily in females who are sexually active and are colonized by a uropathogenic strain of E coli. Subsequently, the periurethral region is colonized from contamination of the colon, and the organism reaches the bladder during sexual intercourse.

      Uropathogenic strains of E coli have an adherence factor called P fimbriae, or pili, which binds to the P blood group antigen. These P fimbriae mediate the attachment of E coli to uroepithelial cells. Thus, patients with intestinal carriage of E coli that contains P fimbriae are at greater risk of developing UTI than the general population. Complicated UTI and pyelonephritis are observed in elderly patients with structural abnormalities or obstruction such as prostatic hypertrophy or neurogenic bladders or in patients with indwelling urinary catheters. Escherichia coli right sided pyelonephritis is visualized in the image below.

      Escherichia coli right pyelonephritis. Escherichia coli right pyelonephritis.
      View Media Gallery

      E coli bacteremia usually is associated with UTIs, especially in cases of urinary tract obstruction of any cause. The systemic reaction to endotoxin (cytokines) or lipopolysaccharides can lead to disseminated intravascular coagulation and death. E coli is a leading cause of nosocomial bacteremia from a GI or genitourinary source.

      Other infections

      Other miscellaneous E coli infections include septic arthritis, endophthalmitis, suppurative thyroiditis, sinusitis, osteomyelitis, endocarditis, and skin and soft-tissue infections (especially in patients with diabetes).

      Previous
      Next:

      Epidemiology

      Frequency

      United States

      E coli ;is the leading cause of both community-acquired and nosocomial UTI. Up to 50% of females eventually experience at least 1 episode of UTI, and up to 10% of post-menopausal individuals report having a UTI within the past year. [5] ;E coli ;causes 12-50% of nosocomial infections and 4% of cases of diarrheal disease.

      International

      In tropical countries, EPEC is an important cause of childhood diarrhea. ETEC causes 11-15% of cases of traveler's diarrhea in persons visiting developing countries and 30-45% of cases of traveler's diarrhea among those visiting Mexico. EAggEC causes 30% of cases of traveler's diarrhea.

      Mortality/Morbidity

      E coli ;neonatal meningitis carries a mortality rate of up to 10%, and most survivors have neurological or developmental abnormalities.

      The mortality and morbidity associated with ;E coli ;bacteremia is the same as that for other aerobic gram-negative bacilli.

      Race

      E coli infections have no recognized racial predilection.

      Sex

      E coli UTI is more common in females than in males because of differences in anatomic structure and changes during sexual maturation, pregnancy, and childbirth.

      Men older than 45 years with prostatic hypertrophy are at an increased risk for UTI due to related bladder stasis.

      Among neonates,E coli UTI is more common in boys than in girls, but circumcision reduces the risk.

      Age

      E coli is an important cause of meningitis in neonates. In previously healthy adults E coli, or other gram-negative meningitis, may occur in the setting of Strongyloidiasis hyper infection and translocation in the setting of steroid use.

      E coli meningitis in isolation is due only to open CNS trauma or neurosurgical procedures.

      Previous
      Clinical Presentation
       
       
      Media Gallery
      of 4
      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
      Editions
      English Deutsch Español Français Português UK
      All material on this website is protected by copyright, Copyright © 1994-2023 by WebMD LLC. This website also contains material copyrighted by 3rd parties.